Published in J Virol on January 09, 2013
Tetraspanins in extracellular vesicle formation and function. Front Immunol (2014) 1.56
The evolving field of human papillomavirus receptor research: a review of binding and entry. J Virol (2013) 1.20
Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses. PLoS Pathog (2014) 1.16
Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16. J Virol (2013) 1.06
Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry. J Virol (2013) 1.01
The papillomavirus major capsid protein L1. Virology (2013) 0.98
Concepts of papillomavirus entry into host cells. Curr Opin Virol (2013) 0.93
Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev (2015) 0.88
Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression. BMC Cancer (2015) 0.87
Topography of the Human Papillomavirus Minor Capsid Protein L2 during Vesicular Trafficking of Infectious Entry. J Virol (2015) 0.87
Incoming human papillomavirus type 16 genome resides in a vesicular compartment throughout mitosis. Proc Natl Acad Sci U S A (2016) 0.85
Inhibition by cellular vacuolar ATPase impairs human papillomavirus uncoating and infection. Antimicrob Agents Chemother (2014) 0.84
The extracellular δ-domain is essential for the formation of CD81 tetraspanin webs. Biophys J (2014) 0.84
Human papillomavirus species-specific interaction with the basement membrane-resident non-heparan sulfate receptor. Viruses (2014) 0.82
Tannins from Hamamelis virginiana bark extract: characterization and improvement of the antiviral efficacy against influenza A virus and human papillomavirus. PLoS One (2014) 0.81
HPV16 infection of HaCaTs is dependent on β4 integrin, and α6 integrin processing. Virology (2013) 0.81
The tetraspanin CD151 in papillomavirus infection. Viruses (2014) 0.81
The CD63-Syntenin-1 Complex Controls Post-Endocytic Trafficking of Oncogenic Human Papillomaviruses. Sci Rep (2016) 0.81
Identification of TRAPPC8 as a host factor required for human papillomavirus cell entry. PLoS One (2013) 0.80
Mutations in the X-linked intellectual disability gene, zDHHC9, alter autopalmitoylation activity by distinct mechanisms. J Biol Chem (2014) 0.78
Interaction of human tumor viruses with host cell surface receptors and cell entry. Viruses (2015) 0.78
Super-resolution microscopy: a virus' eye view of the cell. Viruses (2014) 0.78
Tetraspanin CD151 Promotes Initial Events in Human Cytomegalovirus Infection. J Virol (2016) 0.77
Characterization of an experimental vaccine for bovine respiratory syncytial virus. Clin Vaccine Immunol (2014) 0.77
Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins. J Virol (2016) 0.76
Pancreatic cancer stem cell markers and exosomes - the incentive push. World J Gastroenterol (2016) 0.76
Cruising the cellular highways: How human papillomavirus travels from the surface to the nucleus. Virus Res (2016) 0.76
Coronavirus and influenza virus proteolytic priming takes place in tetraspanin-enriched membrane microdomains. J Virol (2015) 0.75
Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes. Cancer Cell Int (2013) 0.75
The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis. J Virol (2016) 0.75
Incoming human papillomavirus 16 genome is lost in PML protein-deficient HaCaT keratinocytes. Cell Microbiol (2016) 0.75
The specificity of homomeric clustering of CD81 is mediated by its δ-loop. FEBS Open Bio (2017) 0.75
HPV virions hitchhike a ride on retromer complexes. Proc Natl Acad Sci U S A (2013) 0.75
Human papillomavirus major capsid protein L1 remains associated with the incoming viral genome throughout the entry process. J Virol (2017) 0.75
Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus. MBio (2017) 0.75
Efficient intracellular assembly of papillomaviral vectors. J Virol (2004) 5.36
The tetraspanin superfamily: molecular facilitators. FASEB J (1997) 4.29
Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys J (1991) 4.07
Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) (2006) 3.74
Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res (2009) 3.70
Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev (2004) 3.52
Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol Cell (2000) 3.44
The papillomavirus life cycle. J Clin Virol (2005) 3.41
Tetraspanins. Cell Mol Life Sci (2001) 3.33
Human papillomavirus infection requires cell surface heparan sulfate. J Virol (2001) 3.32
Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci (2001) 3.20
The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem (1999) 3.16
Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends Cell Biol (2009) 2.82
Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol (1997) 2.58
Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci U S A (2004) 2.43
Arrangement of L2 within the papillomavirus capsid. J Virol (2008) 2.37
Specific tetraspanin functions. J Cell Biol (2001) 2.35
Atomic model of the papillomavirus capsid. EMBO J (2002) 2.27
A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol (2006) 2.16
Further evidence that papillomavirus capsids exist in two distinct conformations. J Virol (2003) 2.02
Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J Virol (2001) 2.02
Tetraspanins as regulators of protein trafficking. Traffic (2006) 1.98
Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J Virol (2007) 1.96
Palmitoylation supports assembly and function of integrin-tetraspanin complexes. J Cell Biol (2004) 1.89
Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis. PLoS Pathog (2012) 1.76
Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids. J Virol (2008) 1.73
Human papillomaviruses bind a basal extracellular matrix component secreted by keratinocytes which is distinct from a membrane-associated receptor. Virology (2005) 1.73
Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J Virol (1995) 1.70
Human papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusions. PLoS Pathog (2008) 1.69
Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol (2006) 1.67
CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Cancer Res (2008) 1.64
Tetraspanin CD151 regulates alpha6beta1 integrin adhesion strengthening. Proc Natl Acad Sci U S A (2003) 1.63
Clathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs). PLoS One (2008) 1.63
An extracellular site on tetraspanin CD151 determines alpha 3 and alpha 6 integrin-dependent cellular morphology. J Cell Biol (2002) 1.61
Expression of the palmitoylation-deficient CD151 weakens the association of alpha 3 beta 1 integrin with the tetraspanin-enriched microdomains and affects integrin-dependent signaling. J Biol Chem (2002) 1.58
Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS Pathog (2009) 1.57
Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2. J Virol (2006) 1.53
Association of the tetraspanin CD151 with the laminin-binding integrins alpha3beta1, alpha6beta1, alpha6beta4 and alpha7beta1 in cells in culture and in vivo. J Cell Sci (2002) 1.51
Early steps of the hepatitis C virus life cycle. Cell Microbiol (2007) 1.51
Differential stability of tetraspanin/tetraspanin interactions: role of palmitoylation. FEBS Lett (2002) 1.48
Human papillomaviruses, cervical cancer and cell polarity. Oncogene (2008) 1.47
Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells. Virology (1999) 1.45
Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein. J Gen Virol (1994) 1.44
Interactions between papillomavirus L1 and L2 capsid proteins. J Virol (2003) 1.41
Analysis of the CD151-alpha3beta1 integrin and CD151-tetraspanin interactions by mutagenesis. J Biol Chem (2001) 1.37
Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections. PLoS Pathog (2012) 1.36
Reorganization of nuclear domain 10 induced by papillomavirus capsid protein l2. Virology (2002) 1.36
Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry. J Virol (2012) 1.34
Tetraspanin proteins as organisers of membrane microdomains and signalling complexes. Cell Signal (2003) 1.32
Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets. Expert Rev Mol Med (2010) 1.30
Identification of the dynein light chains required for human papillomavirus infection. Cell Microbiol (2011) 1.29
Tetraspanin CD151 promotes cell migration by regulating integrin trafficking. J Biol Chem (2007) 1.24
Homophilic interactions of Tetraspanin CD151 up-regulate motility and matrix metalloproteinase-9 expression of human melanoma cells through adhesion-dependent c-Jun activation signaling pathways. J Biol Chem (2006) 1.23
Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17. Traffic (2012) 1.23
Hepatitis C virus entry: beyond receptors. Rev Med Virol (2012) 1.23
Tetraspanins in viral infections: a fundamental role in viral biology? J Virol (2005) 1.16
Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies: basis for a virus-like particle ELISA. J Med Virol (2005) 1.15
Structure, attachment and entry of polyoma- and papillomaviruses. Virology (2009) 1.11
Papillomavirus virus-like particles activate the PI3-kinase pathway via alpha-6 beta-4 integrin upon binding. Virology (2006) 1.10
alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP. Biochem Biophys Res Commun (2001) 1.08
Usage of heparan sulfate, integrins, and FAK in HPV16 infection. Virology (2010) 1.08
Mechanisms of cell entry by human papillomaviruses: an overview. Virol J (2010) 1.04
Tetraspanin CD151 regulates transforming growth factor beta signaling: implication in tumor metastasis. Cancer Res (2010) 1.04
The emerging role of tetraspanin microdomains on endothelial cells. Biochem Soc Trans (2011) 0.99
Tetraspanin functions during HIV-1 and influenza virus replication. Biochem Soc Trans (2011) 0.94
Tetraspanin CD151 regulates glycosylation of (alpha)3(beta)1 integrin. J Biol Chem (2008) 0.93
Host-cell factors involved in papillomavirus entry. Med Microbiol Immunol (2012) 0.92
Tetraspanins: gateways for infection. Infect Disord Drug Targets (2012) 0.91
The role of tetraspanins in the pathogenesis of infectious diseases. Microbes Infect (2009) 0.90
Polyethylenimine is a strong inhibitor of human papillomavirus and cytomegalovirus infection. Antimicrob Agents Chemother (2011) 0.88
The effect of cell-ECM adhesion on signalling via the ErbB family of growth factor receptors. Biochem Soc Trans (2011) 0.88
Principles of polyoma- and papillomavirus uncoating. Med Microbiol Immunol (2012) 0.79
The cytoskeleton in papillomavirus infection. Viruses (2011) 0.78
A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol (2006) 2.16
Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J Virol (2007) 1.96
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res (2013) 1.92
Clathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs). PLoS One (2008) 1.63
Cytochrome p450 epoxygenase promotes human cancer metastasis. Cancer Res (2007) 1.55
Identification of a dynein interacting domain in the papillomavirus minor capsid protein l2. J Virol (2006) 1.53
Phosphatidylinositol 4-kinase is required for endosomal trafficking and degradation of the EGF receptor. J Cell Sci (2006) 1.53
The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases. Adv Drug Deliv Rev (2011) 1.35
Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled. J Biol Chem (2009) 1.34
Syntenin-1 is a new component of tetraspanin-enriched microdomains: mechanisms and consequences of the interaction of syntenin-1 with CD63. Mol Cell Biol (2006) 1.32
Identification of the dynein light chains required for human papillomavirus infection. Cell Microbiol (2011) 1.29
Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70. J Virol (2004) 1.27
Tetraspanin CD151 promotes cell migration by regulating integrin trafficking. J Biol Chem (2007) 1.24
KAI1/CD82, a tumor metastasis suppressor. Cancer Lett (2005) 1.23
The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity. Cancer Res (2004) 1.22
Tetraspanins in human epithelial malignancies. J Pathol (2010) 1.19
CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium. Mol Cancer Res (2009) 1.15
Dissection of human papillomavirus type 33 L2 domains involved in nuclear domains (ND) 10 homing and reorganization. Virology (2003) 1.14
The tumour-associated antigen L6 (L6-Ag) is recruited to the tetraspanin-enriched microdomains: implication for tumour cell motility. J Cell Sci (2008) 1.11
The tetraspanin CD151 functions as a negative regulator in the adhesion-dependent activation of Ras. J Biol Chem (2003) 1.08
Nuclear localization but not PML protein is required for incorporation of the papillomavirus minor capsid protein L2 into virus-like particles. J Virol (2004) 1.08
A ligation-independent cloning method using nicking DNA endonuclease. Biotechniques (2010) 1.06
Extravasation of polymeric nanomedicines across tumor vasculature. Adv Drug Deliv Rev (2010) 1.04
Suppression of integrin alpha3beta1 in breast cancer cells reduces cyclooxygenase-2 gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cells. Cancer Res (2010) 1.04
Tetraspanin CD82 regulates compartmentalisation and ligand-induced dimerization of EGFR. J Cell Sci (2003) 1.04
Tetraspanin CD151 regulates transforming growth factor beta signaling: implication in tumor metastasis. Cancer Res (2010) 1.04
Tetraspanin CD151 regulates growth of mammary epithelial cells in three-dimensional extracellular matrix: implication for mammary ductal carcinoma in situ. Cancer Res (2010) 1.03
Gamma-adaptin, a novel ubiquitin-interacting adaptor, and Nedd4 ubiquitin ligase control hepatitis B virus maturation. J Biol Chem (2006) 1.02
Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry. J Virol (2013) 1.01
High level HPV-16 E7 oncoprotein expression correlates with reduced pRb-levels in cervical biopsies. FASEB J (2004) 1.01
Lipid and peptide control of phosphatidylinositol 4-kinase IIalpha activity on Golgi-endosomal Rafts. J Biol Chem (2005) 1.00
Identification of Tspan9 as a novel platelet tetraspanin and the collagen receptor GPVI as a component of tetraspanin microdomains. Biochem J (2009) 1.00
Mammalian BiP controls posttranslational ER translocation of the hepatitis B virus large envelope protein. FEBS Lett (2008) 1.00
Nuclear insulin-like growth factor binding protein-3 induces apoptosis and is targeted to ubiquitin/proteasome-dependent proteolysis. Cancer Res (2006) 0.99
Confocal laser endomicroscopy for diagnosis and histomorphologic imaging of brain tumors in vivo. PLoS One (2012) 0.99
Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin alpha6-mediated cell adhesion. J Biol Chem (2004) 0.98
Tetraspanins and tumor progression. Clin Exp Metastasis (2010) 0.98
Regulation of urokinase receptor proteolytic function by the tetraspanin CD82. J Biol Chem (2005) 0.98
Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis. Am J Pathol (2008) 0.97
Gangliosides play an important role in the organization of CD82-enriched microdomains. Biochem J (2006) 0.96
DNA binding of L1 is required for human papillomavirus morphogenesis in vivo. Virology (2002) 0.96
CD151 gene delivery after myocardial infarction promotes functional neovascularization and activates FAK signaling. Mol Med (2009) 0.95
CD82 endocytosis and cholesterol-dependent reorganization of tetraspanin webs and lipid rafts. FASEB J (2009) 0.95
Tissue kallikrein reverses insulin resistance and attenuates nephropathy in diabetic rats by activation of phosphatidylinositol 3-kinase/protein kinase B and adenosine 5'-monophosphate-activated protein kinase signaling pathways. Endocrinology (2007) 0.94
Tetraspanin CD9 in cell migration. Biochem Soc Trans (2011) 0.94
Impact of VP1-specific protein sequence motifs on adeno-associated virus type 2 intracellular trafficking and nuclear entry. J Virol (2012) 0.94
Tetraspanin CD151 regulates glycosylation of (alpha)3(beta)1 integrin. J Biol Chem (2008) 0.93
Interacting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infection. J Biol Chem (2011) 0.92
Host-cell factors involved in papillomavirus entry. Med Microbiol Immunol (2012) 0.92
Tetraspanins and vascular functions. Cardiovasc Res (2009) 0.90
Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81. J Virol (2012) 0.90
The role of tetraspanin CD63 in antigen presentation via MHC class II. Eur J Immunol (2011) 0.89
The microenvironmental determinants for kidney epithelial cyst morphogenesis. Eur J Cell Biol (2008) 0.89
The effect of cell-ECM adhesion on signalling via the ErbB family of growth factor receptors. Biochem Soc Trans (2011) 0.88
Polyethylenimine is a strong inhibitor of human papillomavirus and cytomegalovirus infection. Antimicrob Agents Chemother (2011) 0.88
Tetraspanin CD151 maintains vascular stability by balancing the forces of cell adhesion and cytoskeletal tension. Blood (2011) 0.87
Duck hepatitis B virus requires cholesterol for endosomal escape during virus entry. J Virol (2008) 0.86
Binding to syntenin-1 protein defines a new mode of ubiquitin-based interactions regulated by phosphorylation. J Biol Chem (2011) 0.86
Circulating DBP level and prognosis in operated lung cancer: an exploration of pathophysiology. Eur Respir J (2012) 0.84
Inhibition by cellular vacuolar ATPase impairs human papillomavirus uncoating and infection. Antimicrob Agents Chemother (2014) 0.84
Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition. Exp Cell Res (2006) 0.84
The extracellular δ-domain is essential for the formation of CD81 tetraspanin webs. Biophys J (2014) 0.84
Two origins of blastemal progenitors define blastemal regeneration of zebrafish lower jaw. PLoS One (2012) 0.84
Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor. J Biol Chem (2013) 0.82
Tetraspanin CO-029 inhibits colorectal cancer cell movement by deregulating cell-matrix and cell-cell adhesions. PLoS One (2012) 0.81
An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16. Cell Microbiol (2014) 0.81
Regional variation of the alphabeta T cell repertoire in the colon of healthy individuals and patients with Crohn's disease. Hum Immunol (2002) 0.81
The CD63-Syntenin-1 Complex Controls Post-Endocytic Trafficking of Oncogenic Human Papillomaviruses. Sci Rep (2016) 0.81
Tetraspanins regulate the protrusive activities of cell membrane. Biochem Biophys Res Commun (2011) 0.80
Human papillomavirus type 16 E7 oncoprotein inhibits apoptosis mediated by nuclear insulin-like growth factor-binding protein-3 by enhancing its ubiquitin/proteasome-dependent degradation. Carcinogenesis (2007) 0.79
Tetraspanin CD82 inhibits protrusion and retraction in cell movement by attenuating the plasma membrane-dependent actin organization. PLoS One (2012) 0.79
The transcription factors TBX2 and TBX3 interact with human papillomavirus 16 (HPV16) L2 and repress the long control region of HPVs. J Virol (2013) 0.79
Isolation and characterization of pathogen-bearing endosomes enable analysis of endosomal escape and identification of new cellular cofactors of infection. Methods Mol Biol (2013) 0.78
Adeno associated viral vector-delivered and hypoxia response element-regulated CD151 expression in ischemic rat heart. Acta Pharmacol Sin (2011) 0.78
Time point-based integrative analyses of deep-transcriptome identify four signal pathways in blastemal regeneration of zebrafish lower jaw. Stem Cells (2015) 0.78
MYC-mediated synthetic lethality for treatment of hematological malignancies. Curr Cancer Drug Targets (2015) 0.77
The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial. Biomaterials (2009) 0.77
Differential functions of phospholipid binding and palmitoylation of tumour suppressor EWI2/PGRL. Biochem J (2011) 0.77
The tetraspanin CD151-ARSA mutant inhibits angiogenesis via the YRSL sequence. Mol Med Rep (2012) 0.77
MYC-mediated synthetic lethality for treating tumors. Curr Cancer Drug Targets (2015) 0.76
Purification of integrins and characterization of integrin-associated proteins. Methods Cell Biol (2002) 0.75